Literature DB >> 28119185

Genetic variants of dopamine D2 receptor impact heterodimerization with dopamine D1 receptor.

Ewa Błasiak1, Sylwia Łukasiewicz2, Kinga Szafran-Pilch3, Marta Dziedzicka-Wasylewska4.   

Abstract

BACKGROUND: The human dopamine D2 receptor gene has three polymorphic variants that alter its amino acid sequence: alanine substitution by valine in position 96 (V96A), proline substitution by serine in position 310 (P310S) and serine substitution by cysteine in position 311 (S311C). Their functional role has never been the object of extensive studies, even though there is some evidence that their occurrence correlates with schizophrenia.
METHODS: The HEK293 cell line was transfected with dopamine D1 and D2 receptors (or genetic variants of the D2 receptor), coupled to fluorescent proteins which allowed us to measure the extent of dimerization of these receptors, using a highly advanced biophysical approach (FLIM-FRET). Additionally, Fluoro-4 AM was used to examine changes in the level of calcium release after ligand stimulation of cells expressing different combinations of dopamine receptors.
RESULTS: Using FLIM-FRET experiments we have shown that in HEK 293 expressing dopamine receptors, polymorphic mutations in the D2 receptor play a role in dimmer formation with the dopamine D1 receptor. The association level of dopamine receptors is affected by ligand administration, with variable effects depending on polymorphic variant of the D2 dopamine receptor. We have found that the level of heteromer formation is reflected by calcium ion release after ligand stimulation and have observed variations of this effect dependent on the polymorphic variant and the ligand.
CONCLUSION: The data presented in this paper support the hypothesis on the role of calcium signaling regulated by the D1-D2 heteromer which may be of relevance for schizophrenia etiology.
Copyright © 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Dopamine D1 receptor; Dopamine D2 receptor; G-protein coupled receptors; Oligomerization; Polymorphism

Mesh:

Substances:

Year:  2016        PMID: 28119185     DOI: 10.1016/j.pharep.2016.10.016

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  4 in total

1.  Analysis of the Promoter Region of Human Dopamine Receptor D1.

Authors:  Xue Wu; Feng-Ling Xu; Bao-Jie Wang; Jun Yao
Journal:  J Mol Neurosci       Date:  2018-07-18       Impact factor: 3.444

2.  Functional analysis of 5 upstream polymorphic variations of the human dopamine D1 receptor gene.

Authors:  Xue Wu; Jing-Hua Meng; Feng-Ling Xu; Bao-Jie Wang; Jun Yao
Journal:  J Cell Mol Med       Date:  2019-05-26       Impact factor: 5.310

3.  A comprehensive in silico investigation into the nsSNPs of Drd2 gene predicts significant functional consequences in dopamine signaling and pharmacotherapy.

Authors:  Samia Sultana Lira; Ishtiaque Ahammad
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

4.  Role of Dopamine Receptors in the Anticancer Activity of ONC201.

Authors:  Christina Leah B Kline; Marie D Ralff; Amriti R Lulla; Jessica M Wagner; Phillip H Abbosh; David T Dicker; Joshua E Allen; Wafik S El-Deiry
Journal:  Neoplasia       Date:  2017-12-05       Impact factor: 5.715

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.